Could an experimental drug “cure” cancer?
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What Is Dostarlimab, the Drug Used in ‘Unprecedented' Cancer Trial?A newly disclosed cancer study had “unprecedented” and “unheard-of” results, and now all eyes are on dostarlimab, the GlaxoSmithKline drug used to achieve complete remission in the trial. Developed by a biotech company out of Massachusetts called Tesaro before being acquired by GlaxoSmithKline in 2019, dostarlimab is also known by the brand name Jemparli. First approved in the United States…
Read more »
Every Single Patient in This Small Experimental Drug Trial Saw Their Cancer DisappearIn what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission.
Read more »
Experimental rectal cancer drug caused all patients' tumors to disappear in small trialSo far, no patient has needed further treatment.
Read more »
Every cancer patient enters remission after drug trial, study revealsA recent drug trial administered at Memorial Sloan Kettering Cancer Center to a handful of cancer patients wiped out the disease in every participant.
Read more »
'Tumors just vanished': Cancer patients now in remission after drug trial - CNN VideoAn immunotherapy showed promising results in a small trial of rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. ErinBurnett talks to oncologist Dr. Andrea Cercek about the trial:
Read more »
A breakthrough drug trial astonished doctors by curing rectal cancer in each patientIn a small-scale experiment being conducted on 12 patients with rectal cancer, researchers tested an immunotherapy drug called dostarlimab and the results astonished scientists with remission in every patient.
Read more »